CONNAUGHTON BERNADETTE sold 4.1% of their position (1.63K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $103.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001159036-26-000055
Director
Since Sep 2018
-1.63K
Net shares
Net seller
$103.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.63K
Price / share
$63.48
Trade value
$103.16K
% of position
4.1%
5/1/2026
40.12K→38.50K
Total
Net shares
−1.63K
Net value
-$103.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −1.63K | $63.48 | $103.16K | 4.1% | 40.12K | 38.50K |
| Total | −1.63K | -$103.16K | ||||||
Derivative Transactions0
No derivative transactions reported